World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT00010101
Date of registration: 02/02/2001
Prospective Registration: Yes
Primary sponsor: Pediatric Brain Tumor Consortium
Public title: Genetic Study of Brain Tumors in Young Children
Scientific title: INI1 Mutation Analysis and Expression Profiling of Embryonal CNS Tumors
Date of first enrolment: March 2001
Target sample size: 38
Recruitment status: Terminated
URL:  http://clinicaltrials.gov/show/NCT00010101
Study type:  Observational
Study design:  Observational Model: Case-Only, Time Perspective: Cross-Sectional  
Phase:  N/A
Countries of recruitment
United States
Contacts
Name:     Jaclyn A. Biegel, PhD
Address: 
Telephone:
Email:
Affiliation:  Children's Hospital of Philadelphia
Key inclusion & exclusion criteria

DISEASE CHARACTERISTICS:

- Histologically confirmed primary intracranial central nervous system tumor

- Medulloblastoma

- Primitive neuroectodermal tumor

- Atypical teratoid/rhabdoid tumor

- Choroid plexus carcinoma

- Potential enrollment on PBTC-001 therapeutic protocol

PATIENT CHARACTERISTICS:

Age:

- Under 3

Performance status:

- Not specified

Life expectancy:

- Not specified

Hematopoietic:

- Not specified

Hepatic:

- Not specified

Renal:

- Not specified

PRIOR CONCURRENT THERAPY:

Biologic therapy:

- Not specified

Chemotherapy:

- No prior chemotherapy

Endocrine therapy:

- Prior steroids allowed

Radiotherapy:

- No prior radiotherapy

Surgery:

- Not specified

Other:

- No concurrent investigational agents



Age minimum: N/A
Age maximum: 3 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Central Nervous System Tumor, Pediatric
Intervention(s)
Primary Outcome(s)
Deletions and mutations of the INI1 gene in infants with AT/RT, medulloblastoma, PNET, or choroid plexus carcinoma [Time Frame: No]
Secondary Outcome(s)
Secondary ID(s)
PBTC-N03
CDR0000068445
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
National Cancer Institute (NCI)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history